IRIX Earnings

IRIX reported its earnings on 2026-03-26, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following IRIX's earnings announcement on 2026-03-26, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, IRIX's stock price tends to shift by an average of 9.74% in the 10 days leading up to earnings and -1.23% in the 10 days following, providing insight into potential market.

For 2025/Q3, analysts estimate IRIX's annual revenue to reach 13.10M, while the EPS is projected at -0.06. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between IRIX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, IRIX's stock price typically moves by 9.74% in the 10 days before its earnings and -1.23% in the 10 days after. For the upcoming 2025/Q3 earnings, analysts expect an EPS of -0.06 and revenue of 13.10M.

The earnings call shows mixed signals: positive revenue growth and strategic initiatives, but concerns about supply chain disruptions and competitive pressures. While there is a clear path to profitability, the current financials show a net loss and reduced gross margins. The absence of clear shareholder return plans and the absence of positive analyst sentiment in the Q&A further support a neutral outlook. Without market cap data, the stock's sensitivity to these factors is uncertain, suggesting a neutral prediction for the stock price over the next two weeks.